Definition/General
Introduction:
Duct ectasia is a benign breast condition characterized by the dilation of the large subareolar ducts
It is often associated with periductal inflammation and fibrosis.
Origin:
The cause is unknown, but it is thought to be related to aging and involution of the breast.
Classification:
It is a benign, non-proliferative breast lesion.
Epidemiology:
It is most common in perimenopausal and postmenopausal women
It is also a common cause of nipple discharge in this age group.
Clinical Features
Presentation:
Can present with multicolored, sticky nipple discharge, a palpable subareolar mass, nipple retraction, or breast pain.
Symptoms:
Nipple discharge is the most common symptom
The discharge can be white, yellow, green, or brown.
Risk Factors:
Smoking is a known risk factor.
Screening:
Mammography can show dilated retroareolar ducts, calcifications, or a mass.
Master Duct Ectasia Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
The subareolar ducts are dilated and filled with thick, cheesy, or pasty material.
Characteristics:
The duct walls may be thickened.
Size Location:
Affects the large ducts in the subareolar region.
Multifocality:
Can be bilateral.
Microscopic Description
Histological Features:
The ducts are dilated and filled with proteinaceous debris and foamy macrophages
The duct lining may be attenuated or show apocrine metaplasia
A prominent periductal inflammatory infiltrate, rich in plasma cells (plasma cell mastitis), is characteristic
Periductal fibrosis is also common.
Cellular Characteristics:
The key feature is the presence of foamy macrophages within the duct lumen.
Architectural Patterns:
Ductal dilation with periductal inflammation and fibrosis.
Grading Criteria:
This is a benign lesion.
Immunohistochemistry
Positive Markers:
Not typically required for diagnosis.
Negative Markers:
Not typically required for diagnosis.
Diagnostic Utility:
IHC is not used for diagnosis.
Molecular Subtypes:
Molecular subtyping is not relevant for this benign condition.
Molecular/Genetic
Genetic Mutations:
This is a benign condition and is not associated with specific genetic mutations.
Molecular Markers:
No specific molecular markers are routinely used for diagnosis.
Prognostic Significance:
Duct ectasia is not associated with an increased risk of breast cancer.
Therapeutic Targets:
Treatment is symptomatic
If a mass is present, surgical excision may be necessary to rule out malignancy.
Differential Diagnosis
Similar Entities:
DCIS, especially comedo-type
Intraductal papilloma.
Distinguishing Features:
Comedo-DCIS has high-grade malignant cells and central necrosis
Intraductal papilloma has a papillary architecture.
Diagnostic Challenges:
The main challenge is to distinguish duct ectasia with reactive epithelial changes from DCIS.
Rare Variants:
There are no specific rare variants.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
[specimen type], measuring [size] cm in greatest dimension
Diagnosis
[diagnosis name]
Classification
Classification: [classification system] [grade/type]
Histological Features
Shows [architectural pattern] with [nuclear features] and [mitotic activity]
Size and Extent
Size: [X] cm, extent: [local/regional/metastatic]
Margins
Margins are [involved/uninvolved] with closest margin [X] mm
Lymphovascular Invasion
Lymphovascular invasion: [present/absent]
Lymph Node Status
Lymph nodes: [X] positive out of [X] examined
Special Studies
IHC: [marker]: [result]
Molecular: [test]: [result]
[other study]: [result]
Final Diagnosis
Final diagnosis: [complete diagnosis]